Limited Impact of Fetal Sex and Maternal Body Mass Index on Fetal and Maternal Insulin Resistance and Lipid Metabolism: Findings from the PEARs Study
Anthony R. Rafferty(University College Dublin), Fionnuala M. McAuliffe(University College Dublin), Aisling A. Geraghty(University College Dublin), John Mehegan(University of Bath), Reshma Merin Reji(University College Dublin), Thomas J. Smith(Sidney Kimmel Cancer Center), Ricardo Segurado(University College Dublin), Martina Cronin(National Maternity Hospital), Eileen C. O’Brien(University College Dublin), Maria A. Kennelly(University College Dublin), Orla Maguire(Roswell Park Comprehensive Cancer Center)
Cited by 10
Related Papers
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
|Journal of Clinical Oncology|2003|1.4k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k
American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2009|913
American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options
|Journal of Clinical Oncology|2015|903
Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update
|Journal of Clinical Oncology|2015|896